HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

U.S. metropolitan areas have been identified as hot spots for hiring, job listings and talent migration, according to LinkedIn News’ “Cities on the Rise” list. Hospitals and health systems are among ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Atrium Health Foundation has received more than $4 million in grant funding from The Duke Endowment to expand its digital health and education initiatives, including a virtual nursing program, ...

The success is a result of the partnership between itWorks Learning Center, MOED and Catholic Charities’ Compassionate Caregivers and Level Up programs.

Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

Kentucky shot itself in the foot by passing up a chance to pioneer ibogaine as a promising opioid treatment — an opportunity ...

Liver cancer is a malignant tumor characterized by high incidence and mortality rates worldwide. According to the report by the World Health Organization, ...

Press Release Oncomatryx Biopharma, a biotechnology company pioneering next-generation Antibody-Drug Conjugates (ADCs) for oncology, has been awarded funding from the European Innovation Council (EIC) ...